IR Meeting - Japan MyLab Launch and AI Platform Update
-
Company to hold NDR face-to-face meeting for domestic institutional investors on May 12, 2026, sponsored by Meritz Securities -
Key topics: Japan MyLab launch and global business expansion, development of AI-based digital healthcare platform (BIGNAL)
KOSDAQ Filing Information
- Filing: Holding of Investor Relations Conference (IR)
- Company: HEM Pharma (376270)
- Submission: HEM Pharma Inc.
- Receipt: 05-08-2026
- Under KRX KOSDAQ Market Division